PMID- 37600621 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230823 IS - 2691-171X (Electronic) IS - 2691-171X (Linking) VI - 4 IP - 3 DP - 2023 Aug TI - Delayed Hypersensitivity Reaction to Infliximab Due to Mammalian Meat Allergy. PG - e322 LID - 10.1097/PG9.0000000000000322 [doi] AB - Mammalian meat allergy is a delayed immunoglobulin E (IgE) mediated hypersensitivity reaction to galactose-alpha-1,3-galactose (alpha-gal). Alpha-gal is an oligosaccharide present on glycoproteins and glycolipids of nonprimate mammals as well as biologic agents prepared using mammalian cells including infliximab. We describe a pediatric patient with Crohn's disease who developed urticaria and pruritus roughly 6 hours after her very first infliximab infusion that progressed to chronic urticaria following subsequent infliximab infusions. She was diagnosed with mammalian meat allergy based on an elevated serum IgE level directed against alpha-gal. Her symptoms resolved once infliximab infusions were discontinued and did not recur after commencing therapy with adalimumab. CI - Copyright (c) 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition. FAU - Gonzalez Polanco, Esthermari AU - Gonzalez Polanco E AD - From the Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Virginia, Charlottesville, USA. FAU - Borowitz, Stephen AU - Borowitz S AD - From the Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Virginia, Charlottesville, USA. LA - eng PT - Case Reports DEP - 20230609 PL - United States TA - JPGN Rep JT - JPGN reports JID - 101773885 PMC - PMC10435023 OTO - NOTNLM OT - Infliximab OT - alpha-gal OT - inflammatory bowel disease OT - mammalian meat allergy COIS- The authors report no conflicts of interest. EDAT- 2023/08/21 06:42 MHDA- 2023/08/21 06:43 PMCR- 2023/06/09 CRDT- 2023/08/21 04:48 PHST- 2022/05/25 00:00 [received] PHST- 2023/04/07 00:00 [accepted] PHST- 2023/08/21 06:43 [medline] PHST- 2023/08/21 06:42 [pubmed] PHST- 2023/08/21 04:48 [entrez] PHST- 2023/06/09 00:00 [pmc-release] AID - 10.1097/PG9.0000000000000322 [doi] PST - epublish SO - JPGN Rep. 2023 Jun 9;4(3):e322. doi: 10.1097/PG9.0000000000000322. eCollection 2023 Aug.